J&J’s guselkumab gets EU approval for ulcerative colitis, offering new hope for patients who don’t respond to current treatments.

Ireland has launched its first national clinical genomics study in paediatric oncology, by key stakeholders from the country’s healthcare, life sciences and academic research sectors. 

Boehringer Ingelheim and Tessellate Bio form a €500m partnership to develop precision therapies targeting ALT-positive cancers.

US drug tariffs may not hit branded prices hard, but generics and supply chains face disruption. Here’s what pharma leaders need to know.

FluidForm Bio’s 3D bioprinting tech keeps lab-grown cells alive five times deeper using vascular-like gelatin scaffolds.

The UK government has formally signed into law new clinical trial regulations, designed to modernise operations across the country.

CloudSpec speeds up lipid nanoparticle analysis, cutting lab times from hours to seconds for gene therapy and vaccine research.

The UK government has announced a significant new initiative to accelerate drug discovery and improve patient care in the country.